E3205: Phase II Trial of Cetuximab Plus Cisplatin, 5-Fluorouracil and Radiation in Immunocompetent Patients with Anal Carcinoma
E3205: Phase II Trial of Cetuximab Plus Cisplatin, 5-Fluorouracil and Radiation in Immunocompetent Patients with Anal Carcinoma | |
|---|---|
| Sponsor(s) | Frontier Science and Technology Research Foundation |
| Principal Investigator(s) | John Kauh, MD |
| Dates | 10/11/2010 - 10/10/2012 |
